1 / 1

Optimizing Cardiovascular Therapy for Improved Composite Vascular Endpoint Outcomes

Explore the impact of combination therapy with aspirin, statins, and multiple BP-lowering agents on cumulative survival and risk of composite vascular endpoints over time, based on Lafeber et al.'s study in the American Heart Journal 2013.

mari
Download Presentation

Optimizing Cardiovascular Therapy for Improved Composite Vascular Endpoint Outcomes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 1.00 Combinationtherapy and the occurence of the compositevascularendpoint 0.95 0.90 0.85 Cumulative survival Use of aspirin, a statin and >1 BP-lowering agent: --- yes --- no 0.80 0.75 Time (years) 0 2 4 6 8 10 Lafeberet al., Am.Heart J 2013

More Related